In 2024, SIA "GL Pharma Riga" had revenue of 2.8 million EUR and profit of 51.1 thousand EUR. The company has 9 employees. Beneficial owners: Martin Dr. Bartenstein.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 2,8m € +9.3% | 2,5m € +16.8% | 2,2m € +13.9% |
Profit | 51,1k € +1.1% | 50,6k € +17.2% | 43,1k € +4.6% |
Assets | 930,4k € +13.1% | 822,6k € +10.8% | 742,4k € +21.4% |
Liabilities | 416,9k € +15.7% | 360,2k € +9.0% | 330,6k € +36.2% |
Equity | 513,5k € +11.1% | 462,4k € +12.3% | 411,8k € +11.7% |
Employees | 9 -10.0% | 10 +0.0% | 10 +0.0% |
Overall rating | A+93/100 |
Financial health | 95/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 70/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | Independently |
| Name | Changed |
|---|---|
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
| Sabiedrība ar ierobežotu atbildību "LANNACHER RĪGA" | 16 July 2010 |
SIA "GL Pharma Riga" is located at Rīga, Daugavgrīvas iela 28, LV-1048.
In 2024, SIA "GL Pharma Riga" had revenue of 2 774 347 EUR and profit of 51 126 EUR. Compared to previous year, revenue increased by 9.3%. View full financial report →
In 2024, SIA "GL Pharma Riga" had an average of 9 employees. View tax history →
The beneficial owners of SIA "GL Pharma Riga" are Martin Dr. Bartenstein. View ownership details →
Yes, SIA "GL Pharma Riga" is registered as an active VAT payer with VAT number LV50003715171.
In 2024, the average gross salary at SIA "GL Pharma Riga" was approximately 2474,12 € per month (net ~ 1779,73 €). This is an approximate calculation. View salary details →
SIA "GL Pharma Riga" was founded on December 8, 2004. The company has been operating for 22 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 22 years | 43 - 47 | 85% | |
Net revenue | 2 774 347,00 € | 12 - 16 | 95% | |
Profit | 51 126,00 € | 35 - 39 | 87% | |
Equity | 513 496,00 € | 19 - 23 | 90% | |
Assets | 930 432,00 € | 18 - 22 | 93% | |
Fixed assets | 27 391,00 € | - | 90% | |
Investments | 5458,00 € | - | 50% | |
Liquidity | 2.15 | - | 60% | |
Profitability | 1.8% | - | 10% | |
Registered capital | 2845,00 € | - | 50% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights |
|---|---|---|
| G.L. Pharma GmbH | 2845 | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Martin Dr. Bartenstein | AT | - |